PROS1 and acute respiratory distress syndrome: These results on the synergism between LPS and S protein have clinical and therapeutic importance, as this could give new insights in the comorbidities that may increase the risk for severe COVID-19 disease and ARDS, its pathogenetic steps, as well as provide new therapeutic targets.